Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MagCool: Magnesium Sulphate plus Hypothermia for HIE
NCT01646619Phase 3Unknown
- Start
- May 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of magnesium sulfate in hypoxic-ischemic encephalopathy (HIE). Status: unknown.
02
Drugs
magnesium sulfate
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT01646619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01646619.